Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Entities / Companies / Kyowa Kirin
Company

Kyowa Kirin

Tracked across 2 events · 16 articles · First seen Apr 01, 2026 · Last active Jun 10, 2026

Sentiment
30
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (2)
4 60
Tech
Kyowa Kirin presents mogamulizumab data
Kyowa Kirin announced new clinical data, patient-reported outcomes, real-world utilization, and comparative-effectiveness models for Mogamulizumab, a drug used to treat relapsed or refractory mycosis fungoides and Sézary syndrome. These findings will be presented at the…
Impact: Kyowa Kirin is presenting new data on its drug Mogamulizumab, which could enhance its market position and revenue. The company is the primary entity driving this event.
Jun 10, 2026 · 10 articles
2 0
Business
Ardelyx Appoints Rajani Dinavahi CMO
Impact: Kyowa Kirin commercializes PHOZEVEL (tenapanor) for hyperphosphatemia in Japan, a product related to Ardelyx's pipeline.
Apr 01, 2026 · 6 articles
Key Actions (2)
100 Kyowa Kirin announced new dataKyowa Kirin presents...
90 Kyowa Kirin presented research World Congress of Cutaneous LymphomasKyowa Kirin presents...
NEWSDESK
Track Kyowa Kirin live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.